Canopy Growth Broadens Australian Medical Cannabis Portfolio With New Formats and Formulations

1 hour ago 3

Article content

New pastille and all-in-one vape formats, expanded oil and softgel offerings, and new flower SKUs build on international growth momentum

Financial Post

THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY

Subscribe now to read the latest news in your city and across Canada.

  • Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
  • Daily content from Financial Times, the world's leading global business publication.
  • Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
  • National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
  • Daily puzzles, including the New York Times Crossword.

SUBSCRIBE TO UNLOCK MORE ARTICLES

Subscribe now to read the latest news in your city and across Canada.

  • Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
  • Daily content from Financial Times, the world's leading global business publication.
  • Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
  • National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
  • Daily puzzles, including the New York Times Crossword.

REGISTER / SIGN IN TO UNLOCK MORE ARTICLES

Create an account or sign in to continue with your reading experience.

  • Access articles from across Canada with one account.
  • Share your thoughts and join the conversation in the comments.
  • Enjoy additional articles per month.
  • Get email updates from your favourite authors.

THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.

Create an account or sign in to continue with your reading experience.

  • Access articles from across Canada with one account
  • Share your thoughts and join the conversation in the comments
  • Enjoy additional articles per month
  • Get email updates from your favourite authors

Sign In or Create an Account

or

Article content

SMITHS FALLS, Ontario — Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced a broadening of its medical cannabis portfolio in Australia across its Spectrum Therapeutics, Spectrum Therapeutics Reserve, 7ACRES, Tweed and Twd. brands. The expansion introduces two new product formats, and new formulations within its existing oil and softgel ranges.

Article content

Article content

Article content

“Expanding our product offering in established markets like Australia is central to our international medical strategy,” said Luc Mongeau, Chief Executive Officer, Canopy Growth. “These new formats and formulations reflect the continued strength of our global supply chain and our ability to evolve our existing portfolio while bringing a broader range of high-quality products to international markets.”

Article content

By signing up you consent to receive the above newsletter from Postmedia Network Inc.

Article content

New formats, now available

Article content

  • Pastilles – Canopy Growth’s first pastille format in Australia:
    • Tweed Red 10
    • Tweed Blue 10:10
    • Spectrum Triple Balance 10:10:10
    • Spectrum Dawn 1:10:5
  • All-in-one vapes Canopy Growth’s first AIO vape format in Australia:
    • 7 ACRES Fondant Live Resin AIO Vape 1 mL (Indica)
    • Spectrum Therapeutics Reserve Berea Live Resin AIO Vape 1 mL (Sativa)

Article content

Expanded formulations, now available

Article content

  • Oils – Canopy Growth’s first Australian oils to include CBG and CBN:
    • Spectrum Flow
    • Spectrum Sunset
  • Softgels expanding the range beyond isolate based formulations:
    • Spectrum White 50
    • Spectrum Black 10

Article content

Also new to the portfolio

Article content

  • Flower:
    • Two new SKUs added under the Twd. value range

Article content

“Prescribers and patients in Australia are asking for more choice in format and formulation,” said Andrew Bevan, President, Medical, Canopy Growth. “These launches give clinicians more options to tailor treatment approaches, while our new pastille and oil offerings reflect formulation work shaped by insights from our Canadian clinic and provider network.”

Article content

About Canopy Growth

Article content

Canopy Growth is a leading global company committed to bettering lives through cannabis. With a focus on cultivation excellence, quality, trust, innovation and disciplined execution, Canopy Growth is a consumer-centric company serving patients, consumers and partners alike.

Article content

The Company’s portfolio of owned and licensed brands, including Tweed, 7ACRES, DOJA, Deep Space, DeeLish, Claybourne, MTL Cannabis, Low Key by MTL and R’belle, as well as category-defining Storz & Bickel, delivers innovative cannabis products to consumers across Canada and beyond. It is also Canada’s leading provider of medical cannabis services through Spectrum Therapeutics, Abba Medix, Apollo, and Canada House Clinics.

Article content

The Company also holds an unconsolidated, non-controlling interest in Canopy USA, LLC, which provides exposure to the U.S. THC market.

Article content

Guided by its commitment to leadership, excellence, trust and innovation, Canopy Growth is working to shape a future where the plant is trusted for its ability to better lives.

Article content

For more information visit www.canopygrowth.com

Article content

Article content

Article content

View source version on businesswire.com:

Article content

Article content

logo

Article content

Contacts

Article content

Media Contact:

Article content

Article content

Article content

Investor Contact:

Article content

Article content

Read Entire Article